8000.00
13373.00
4T1细胞mTmem176b基因敲除株(CGKO-M2282)
品质保证
干冰运输另加200元
快速发货
STR检测
物种检测
选择 货号、规格
  • 产品参数
  • 产品详情
  • 说明书
  • 相关产品
  • 产品评论
类型
基因敲除
品牌
Cas9x
产品货号
CGKO-M2282
价格
8000.00
库存量
100
市场价
13373.00
用途
仅供科研使用

产品名称:4T1细胞mTmem176b基因敲除株

产品简称4T1 KO-mTmem176b

产品货号CGKO-M2282

修饰基因:mTmem176b

因ID65963

修饰类型:敲除

转导方法:蛋白电转

抗性基因:

克隆类型:纯合子

细胞鉴定:PCR,测序

种属来源小鼠

组织来源乳腺

疾病特征乳腺癌

细胞形态上皮细胞样

生长特性贴壁生长

培养体系RPMI-1640+10%FBS+1%P/S

配套培养基货号:TCM-G705

传代比例:1:3-1:6,每2-3天换液一次

传代周期48-72 h

培养条件气相:95%空气+5%CO2,温度:37℃

冻存条件60%基础培养基+30%FBS+10%DMSO,液氮储存

质量检测细菌、真菌、支原体检测均为阴性

参考文献:

Pulaski BA, et al. Immunotherapy with vaccines combining MHC class II/CD80+ tumor cells with interleukin-12 reduces established metastatic disease and stimulates immune effectors and monokine induced by interferon gamma. Cancer Immunol. Immunother. 49: 34-45, 2000. PubMed: 10782864


Pulaski BA, Ostrand-Rosenberg S. Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines. Cancer Res. 58: 1486-1493, 1998. PubMed: 9537252


Pulaski BA, et al. Cooperativity of Staphylococcal aureus enterotoxin B superantigen, major histocompatibility complex class II, and CD80 for immunotherapy of advanced spontaneous metastases in a clinically relevant postoperative mouse breast cancer model. Cancer Res. 60: 2710-2715, 2000. PubMed: 10825145


Aslakson CJ, Miller FR. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res. 52: 1399-1405, 1992. PubMed: 1540948


收货当天如何处理细胞?

收到细胞后请务必仔细阅读产品资料,了解细胞相关信息,如贴壁特性 (贴壁/悬浮/半贴壁半悬浮)、细胞形态、培养体系、传代比例和换液频率等。

点击可查看下载《细胞收货处理方法说明》.jpg

首页
客服
购物车
加入购物车
购买